Le Lézard
Classified in: Environment, Health
Subjects: PSF, CPG

Cervids: Chronic Wasting Disease (CWD) - The Ministère is continuing its efforts to prevent CWD from becoming established in Québec and wishes to inform the general public of the measures in place for 2023


QUÉBEC, Sept. 13, 2023 /CNW/ - The Ministère de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs is continuing its enhanced surveillance of chronic wasting disease among cervids in the sector surrounding the deer farm in the Laurentides region at which cases were detected in 2018. The regulations requiring the collection of samples and limiting the transportation of certain anatomical parts of cervid carcasses remain in force in some sections of the Laurentides, Outaouais and Montérégie regions in 2023 (see the areas in which CWD measures apply on the map below).

Registration of white-tailed deer at designated stations

Hunters who kill white-tailed deer (adults or fawns) within a 45-km radius of the farm at which CWD was detected in 2018 must register their kill at one of the designated stations within that radius. Station contact information and opening hours can be found here: Liste des stations d'enregistrement. Online registration is not permitted for this game species.

Mandatory sampling

Hunters who kill a white-tailed deer or moose aged 12 months or older within the 45-km radius must have the carcass analyzed for CWD. To do this, they must go in person to one of the designated registration stations within the 45-km radius, where the Ministère's personnel will take the required samples.

Elsewhere in the province, the Ministère continues its partnerships with certain butchers to carry out analyses of white-tailed deer killed by hunters.

The analysis results can be accessed online at Québec.ca/cervidsdisease.

Limitations on the transportation of certain anatomical parts of cervid carcases

Certain parts (including the head and spine) of white-tailed deer, moose and farmed cervids killed within 45 km of the farm at which CWD was detected in 2018 must remain within the 45-km radius and within the hunting zone in which the animal was killed. Consequently, carcasses must always be registered, cut up or stuffed within the 45-km radius and inside the hunting zone in which the animal was killed. These transportation restrictions are designed to prevent the disease from potentially spreading to other sectors of Québec if it is present in the wild population.

CWD surveillance report - 2022

CWD surveillance in 2022 in the enhanced surveillance area (ESA) met the goals set by the Ministère. In all, 769 white-tailed deer and 28 moose were analyzed in the sector, thanks to the collaboration of hunters. No positive cases were found. These results are encouraging, because they suggest that if the disease is present in the wild population, it has affected very few animals and can therefore still be eliminated.

Elsewhere in the province, 4,555 white-tailed deer and 13 moose were also analyzed through partnerships with butchers. All the results were negative.

For more detailed information, please see the 2022 report on CWD surveillance and control operations.

Lastly, the Ministère encourages hunters to practise their activity responsibly, in compliance with the regulations and safety rules. It also reminds hunters that they must obtain the landowner's permission to hunt on private land.

Quick facts:
Associated links:

Source and information:

 

Media Relations

Ministère de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs

Phone 418 521-3991


SOURCE Ministère de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: